Vaccination against human papillomavirus infection and its clinical utility. Screenandtreat approaches for cervical cancer prevention services in lowresource settings. Optimizing the hybrid capture II human papillomavirus test to detect cervical intraepithelial neoplasia. Reducing HPVrelated clinical disease through vaccination. HPV in screening and triage towards an affordable test. Critical assessment of screening methods for cervical neoplasia. The International Agency for Research on Cancer IARC commitment to cancer prevention the example of papillomavirus and cervical cancer. Prospective, randomized trial of LEEP versus laser excisional conization.

Cervical cancer a call for political will. Read our policies and terms of service. Onesession management of cervical intraepithelial neoplasia a solution for developing countries. The etiology, diagnosis, and natural history of CIN will be reviewed . This report refers to partial results from the LAMS Latin American Screening Study. Preventing cervical cancer in the developing world. Cervical cancer prevention safety, acceptability, and feasibility of a singlevisit approach in Accra, Ghana.

Quadrivalent human papillomavirus vaccine recommendations of the Advisory Committee on Immunization Practices ACIP. Issues in planning cervical cancer screening in the era of HPV vaccination. Screening for cervical cancer in lowresource settings how far have we come and what does the future hold. Research needs following initial licensure of viruslike particle HPV vaccines. HPVmediated cervical carcinogenesis concepts and clinical implications. Please send your feedback, comments and suggestions to our staff. The epidemiology of human papillomavirus type 16 and 18associated cervical cancer. Factors affecting utilization of cervical cancer prevention in low resource settings.

New dimensions in cervical cancer control. Involving the community in cervical cancer screening. Cervical cancer screening from the papanicolaou smear to the vaccine era. Experience using cryotherapy for treatment of cervical precancerous lesions in lowresource settings. Clinical applications of HPV testing a summary of metaanalyses. Public health approach to cervical cancer control considerations of screening and vaccination strategies. Current cervical cancer screening guidelines and impact of prophylactic HPV vaccines. Current findings from prophylactic HPV vaccine trials. Screening and management of precancerous lesions to prevent cervical cancer.

HPV in the etiology of human cancer. Cervarixtrademdasha bivalent L1 viruslike particle vaccine.